Arrowhead Pharmaceuticals, Inc. ARWR
58.16 USD +0.70 (+1.22%)
At closeNov 6, 2026, 4:00 PM EST
58.16 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
57.00 Day range 58.71
38.09 52-week range 89.59
- YTD
- -12.40%
- 1 year
- +46.87%
Revenue & Expenses
Latest period ending Sep 30, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| 829.45M | 3.55M | 240.74M | 243.23M | 138.29M | |
| 829.45M | 3.55M | 240.74M | 243.23M | 138.29M | |
| 98.35M | -601.08M | -205.00M | -178.51M | -149.04M | |
| -1.63M | -599.49M | -205.28M | -176.06M | -140.85M | |
| -0.01 | -5.00 | -1.92 | -1.67 | -1.36 |
Balance sheet
| Fiscal year | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| 226.55M | 102.69M | 110.89M | 108.00M | 184.43M | |
| 1.39B | 1.14B | 765.55M | 691.94M | 710.15M | |
| 881.88M | 948.74M | 478.39M | 273.60M | 301.33M | |
| 733.68M | 851.91M | 383.50M | 81.58M | 25.55M | |
| 466.05M | 185.44M | 271.34M | 398.52M | 408.82M |
Cash flow
| Fiscal year | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| 179.55M | -462.85M | -153.89M | -136.13M | 171.31M | |
| -129.29M | -420.07M | -96.16M | -5.42M | -141.68M | |
| 74.01M | 870.52M | 253.05M | 65.19M | 11.30M | |
| -22.67M | -141.47M | -176.74M | -52.78M | -23.57M | |
| 124.26M | -12.40M | 3.01M | -76.36M | 40.94M |